Roche Diabetes Care patent upheld by UPC; Tandem’s invalidity claims rejected
MLex Summary: The Unified Patent Court has upheld Roche Diabetes Care’s EP 2,196,231 B1, rejecting claims of invalidity made by Tandem Diabetes Care. The Paris Central Division examined whether Roche’s patent...To view the full article, register now.
Already a subscriber? Click here to view full article